Publications
Recent Original Research Publications
1) Gonzalez SA, Liu R-C, Edlin BR, Jacobson IM, Talal AH. Human immunodeficiency virus-hepatitis C virus co-infected patients with normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 2006;41:582-89.
2) Talal AH, Ribeiro R, Powers K, Grace M, Cullen C, Hussain M, Markatou M, Perelson AS. Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from non-responders. Hepatology 2006;43:943-953.
3) Dahari H, Markatou M, Zeremski M, Haller I, Ribeiro RM, Licholai T, Perelson AS, Talal AH. Early Ribavirin Pharmacokinetics, HCV RNA and Alanine Aminotransferase Kinetics in HIV/HCV Co-infected Patients During Treatment with Pegylated Interferon and Ribavirin. J Hepatol 2007;47:23-30.
4) Zeremski M, Markatou M, Dorante G, Brown QB, Cunningham-Rundles S, Talal AH. IP-10: A predictive marker of successful treatment response in hepatitis C virus/human immunodeficiency virus co-infected patients? J Acquir Immune Defic Syndr 2007;45:262-68.
Recent Reviews
1) Kadam JS, Talal AH. Changing treatment paradigms: Hepatitis C virus in HIV-Infected Patients. AIDS Patient Care and STDS 2007;21:154-168.
2) Cheruvu S, Beeder AB, Carden M, Edlin BR, Talal AH. Interventions to control hepatitis C among injection drug users. In: Negro F (ed). Hot Topics in Viral Hepatitis 2007; 6: 23-30.
3) Zeremski M, Talal AH. Hepatitis C Viral Kinetics During Treatment of HCV/HIV Co-infected Patients. Current Opinion in HIV/AIDS (in press).
4) Cheruvu S, Marks K, Talal AH. Understanding The Pathogenesis And Management Of Hepatitis B/Human Immunodeficiency Virus And Hepatitis B/Hepatitis C Virus Coinfection. Clinics in Liver Disease (in press).
5) Zeremski M, Petrovic LM, Talal AH. The Role of Chemokines as Inflammatory Mediators in Chronic Hepatitis C Virus Infection. J Viral Hepatitis (in press).
